Zobrazeno 1 - 10 of 25 pro vyhledávání: '"Armstrong IJ"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Impact of the COVID-19 pandemic on radiology department emergency ultrasound utilization.
Autor: Messina MD; Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY, 10467, USA. MaMessina@montefiore.org., Stein MW; Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY, 10467, USA., Armstrong IJ; Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY, 10467, USA., Wolf EL; Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th Street, Bronx, NY, 10467, USA.
Publikováno v: Emergency radiology [Emerg Radiol] 2021 Oct; Vol. 28 (5), pp. 869-875. Date of Electronic Publication: 2021 Apr 29.
Zobrazit plný text záznamu
6
Akademický článek
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension.
Autor: Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Billings CG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Smith IA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Austin M; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Middleton J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Rothman AMK; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Harrington J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hamilton N; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hameed AG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2021 Jan; Vol. 18 (1), pp. 34-43.
Zobrazit plný text záznamu
7
Akademický článek
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
Autor: Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Johns CS; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Cogliano M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Capener D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Tubman E; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Billings CG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Hamilton N; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Baster K; Statistical Services Unit, School of Mathematics and Statistics and., Laud PJ; Statistical Services Unit, School of Mathematics and Statistics and., Hickey PM; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Middleton J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Rothman AMK; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Feb 15; Vol. 201 (4), pp. 458-468.
Zobrazit plný text záznamu
8
Akademický článek
Exploring a physiotherapy well-being review to deliver community-based rehabilitation in patients with pulmonary hypertension.
Autor: Keen C; Pulmonary Vascular Diseases Unit, Sheffield teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hashmi-Greenwood M; Sheffield Hallam University, Sheffield, UK., York J; School of Health Sciences, UoM, Manchester, UK., Armstrong IJ; Pulmonary Vascular Diseases Unit, Sheffield teaching Hospitals NHS Foundation Trust, Sheffield, UK., Sage K; Sheffield Hallam University, Sheffield, UK., Kiely D; Room M15, Ward M2 Royal Hallamshire Hospital, Sheffield, UK.
Publikováno v: Pulmonary circulation [Pulm Circ] 2019 Nov 05; Vol. 9 (4), pp. 2045894019885356. Date of Electronic Publication: 2019 Nov 05 (Print Publication: 2019).
Zobrazit plný text záznamu
9
Akademický článek
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
Autor: Billings CG; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Lewis R; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK., Hurdman JA; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Condliffe R; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Elliot CA; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Thompson AAR; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK., Smith IA; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Austin M; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Armstrong IJ; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Hamilton N; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Charalampopoulos A; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Sabroe I; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK., Swift AJ; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.; 3 Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sir Frederick Mappin Building, Sheffield, UK., Rothman AM; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK., Wild JM; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.; 3 Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sir Frederick Mappin Building, Sheffield, UK., Lawrie A; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK., Waterhouse JC; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK., Kiely DG; 1 Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK.; 2 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK.; 3 Insigneo Institute for in silico Medicine, University of Sheffield, The Pam Liversidge Building, Sir Frederick Mappin Building, Sheffield, UK.
Publikováno v: Pulmonary circulation [Pulm Circ] 2019 Apr-Jun; Vol. 9 (2), pp. 2045894019848649.
Zobrazit plný text záznamu
10
Editorial & Opinion
Decision-making in pulmonary endarterectomy surgery.
Autor: Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Quadery SR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Jenkins DP; Pulmonary Vascular Disease Unit, Papworth Hospital NHS Foundation Trust, Cambridge, UK., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Pulmonary Hypertension Association, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Publikováno v: The European respiratory journal [Eur Respir J] 2019 Jan 10; Vol. 53 (1). Date of Electronic Publication: 2019 Jan 10 (Print Publication: 2019).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje